Drug discovery benefits from computational models aiding the identification of new chemical matter with bespoke properties. The field of de novo drug design has been particularly revitalized by adaptation of generative machine learning models from the field of natural language
processing. These deep neural network models are trained on recognizing molecular structures and generate new molecular entities without relying on pre-determined sets of molecular building blocks and chemical transformations for virtual molecule construction. Implicit representation of chemical
knowledge provides an alternative to formulating the molecular design task in terms of the established, explicit chemical vocabulary. Here, we review de novo molecular design approaches from the field of 'artificial intelligence', focusing on instances of deep generative models, and
highlight the prospective application of long short-term memory models to hit and lead finding in medicinal chemistry.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, CH-8093 Zurich, Switzerland
ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg 4, CH-8093 Zurich, Switzerland;, Email: [email protected]
Publication date: December 1, 2019
More about this publication?
International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions
CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites